Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 02, 2018 08:56 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

BUENA, N.J., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
August 16, 2018 16:30 ET | Source: Teligent, Inc.

Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage

TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT) (“Teligent”), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by...
August 08, 2018 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Second Quarter 2018 Results

BUENA, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter...
August 03, 2018 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Second Quarter 2018 Results

BUENA, N.J., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
July 30, 2018 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Hydrocortisone Lotion USP, 2.5%

BUENA, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
July 24, 2018 15:03 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5%

BUENA, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
July 02, 2018 08:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Lidocaine and Prilocaine Cream USP, 2.5%/2.5%

BUENA, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
June 20, 2018 09:22 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05%

BUENA, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
June 13, 2018 16:40 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

BUENA, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
June 05, 2018 16:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility

BUENA, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- TELIGENT, Inc. (NASDAQ:TLGT) Teligent, Inc. (“Teligent”) announced today that it has entered into a Credit Agreement with certain funds managed by...